196 related articles for article (PubMed ID: 35002966)
1. Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies.
Zhang J; Ding G; Li J; Li X; Ding L; Li X; Yang S; Tang F
Front Endocrinol (Lausanne); 2021; 12():783439. PubMed ID: 35002966
[TBL] [Abstract][Full Text] [Related]
2. Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis.
Yuan A; Wu J; Huang H
Front Endocrinol (Lausanne); 2024; 15():1384365. PubMed ID: 38715797
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Lowest Effective Initial Dose of Prednisolone for the Treatment of Subacute Granulomatous Thyroiditis: A Systematic Review and Meta-Analysis.
Soltani A; Nourani F; Roudsari SB; Jouybari L; Fathi M; Haghighat S; Hadavi M; Aletaha A
Curr Rev Clin Exp Pharmacol; 2022; 17(2):135-143. PubMed ID: 34636318
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.
Mizukoshi T; Noguchi S; Murakami T; Futata T; Yamashita H
Intern Med; 2001 Apr; 40(4):292-5. PubMed ID: 11334386
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
Arao T; Okada Y; Torimoto K; Kurozumi A; Narisawa M; Yamamoto S; Tanaka Y
J UOEH; 2015 Jun; 37(2):103-10. PubMed ID: 26073499
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcome of Subacute Thyroiditis.
Görges J; Ulrich J; Keck C; Müller-Wieland D; Diederich S; Janssen OE
Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):703-708. PubMed ID: 31546269
[TBL] [Abstract][Full Text] [Related]
7. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.
Christensen J; O'Callaghan K; Sinclair H; Hawke K; Love A; Hajkowicz K; Stewart AG
Intern Med J; 2022 Apr; 52(4):522-529. PubMed ID: 34139048
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan.
Kubota S; Nishihara E; Kudo T; Ito M; Amino N; Miyauchi A
Thyroid; 2013 Mar; 23(3):269-72. PubMed ID: 23227861
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the therapeutic effects of 15 mg and 30 mg initial dosage of prednisolone daily in patients with subacute thyroiditis: protocol for a multicenter, randomized, open, parallel control study.
Xu S; Jiang Y; Jia A; Zhang J; Gao B; Xu J; Jing X; Jiao Y; Wei J; Xu W; Chen R; Gao L; Shang L
Trials; 2020 May; 21(1):418. PubMed ID: 32448401
[TBL] [Abstract][Full Text] [Related]
10. Successful Management of Recurrent Subacute Thyroiditis by Adding Colchicine to Glucocorticoid Treatment: A Case Series Study.
Tian Z; Su Y; Zhang M; Zhang X; Guan Q
Horm Metab Res; 2020 Oct; 52(10):712-717. PubMed ID: 32365399
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis.
Shekarian A; Fakhrolmobasheri M; Mazaheri-Tehrani S; Yousefian A; Heidarpour M
Endocrine; 2024 Apr; 84(1):29-41. PubMed ID: 38147263
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the therapeutic effects of 15 mg and 30 mg initial daily prednisolone doses in patients with subacute thyroiditis: a multicenter, randomized, open-label, parallel-controlled trial.
Zeng J; Jia A; Zhang J; Gao B; Xu J; Xing Y; Jing X; Jiao Y; Wang J; Xu W; Gao L; Shang L; Xu S
Ann Med; 2023; 55(2):2288941. PubMed ID: 38048390
[TBL] [Abstract][Full Text] [Related]
13. An Evaluation of the Results of the Steroid and Non-steroidal Anti-inflammatory Drug Treatments in Subacute Thyroiditis in relation to Persistent Hypothyroidism and Recurrence.
Sencar ME; Calapkulu M; Sakiz D; Hepsen S; Kus A; Akhanli P; Unsal IO; Kizilgul M; Ucan B; Ozbek M; Cakal E
Sci Rep; 2019 Nov; 9(1):16899. PubMed ID: 31729433
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ultrasound-guided intrathyroidal injection of glucocorticoids versus routine oral administration of glucocorticoids for subacute thyroiditis: Protocol of systematic review and meta-analysis.
Li J; Zhang J; Jiang L; Li Z; Li F; Chen H; Feng L
Medicine (Baltimore); 2019 Dec; 98(52):e18564. PubMed ID: 31876758
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Xiaochaihu decoction for subacute thyroiditis: A protocol of systematic review and meta-analysis.
Li L; Yue R; Zeng L; Wang S; Zhuo W; Sun Y
Medicine (Baltimore); 2020 Nov; 99(46):e23011. PubMed ID: 33181665
[TBL] [Abstract][Full Text] [Related]
16. Short-Term Versus 6-Week Prednisone In The Treatment Of Subacute Thyroiditis: A Randomized Controlled Trial.
Duan L; Feng X; Zhang R; Tan X; Xiang X; Shen R; Zheng H
Endocr Pract; 2020 Aug; 26(8):900-908. PubMed ID: 33471681
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients with subacute thyroiditis.
Kjellerup CR; Thomsen MJ; Torp NMU; Karmisholt J; Andersen SL
Dan Med J; 2023 Oct; 70(11):. PubMed ID: 37897374
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of the clinical efficacy and safety of Chinese patent medicines in treating subacute thyroiditis.
Yu H; Wu M; Yang Y; Li W
Ann Palliat Med; 2021 Nov; 10(11):11403-11414. PubMed ID: 34872266
[TBL] [Abstract][Full Text] [Related]
19. New aspects in the pathogenesis and management of subacute thyroiditis.
Stasiak M; Lewiński A
Rev Endocr Metab Disord; 2021 Dec; 22(4):1027-1039. PubMed ID: 33950404
[TBL] [Abstract][Full Text] [Related]
20. Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey.
Erdem N; Erdogan M; Ozbek M; Karadeniz M; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C; Tuzun M; Kabalak T
J Endocrinol Invest; 2007; 30(7):546-50. PubMed ID: 17848836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
